The exception is one experiment that found the co-expression of IL-7 and CCL19, a chemoattractant for T cells and DCs, in CAR-Tcells can extend cell survival and enhance the anti-tumor efficacy of CAR-T cells in mice (139). The gene discussed is IL7; the disease is neoplasm.